Detalhe da pesquisa
1.
Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs.
Mult Scler
; 29(7): 856-865, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37165941
2.
Natalizumab treatment and pregnancy in multiple sclerosis: A reappraisal of maternal and infant outcomes after 6 years.
Mult Scler
; 28(13): 2137-2141, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35296189
3.
Pregnancy in multiple sclerosis women with relapses in the year before conception increases the risk of long-term disability worsening.
Mult Scler
; 28(3): 472-479, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34132146
4.
Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register.
Mult Scler
; 28(14): 2243-2252, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35971322
5.
Cost-utility analysis of teriflunomide in naïve vs. previously treated patients with relapsing-remitting multiple sclerosis in Italy.
Neurol Sci
; 43(8): 4933-4944, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35420360
6.
Predictors of unemployment status in people with relapsing multiple sclerosis: a single center experience.
Neurol Sci
; 43(7): 4387-4392, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35322339
7.
Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factors.
Mult Scler
; 27(3): 430-438, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33210986
8.
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study.
Eur J Neurol
; 28(4): 1299-1307, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33305459
9.
Long-term comparative analysis of no evidence of disease activity (NEDA-3) status between multiple sclerosis patients treated with natalizumab and fingolimod for up to 4 years.
Neurol Sci
; 42(11): 4647-4655, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33677753
10.
Coverage of the requirements of first and second level stroke unit in Italy.
Neurol Sci
; 42(3): 1073-1079, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32737805
11.
Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study.
J Neurol Neurosurg Psychiatry
; 91(9): 914-920, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32661083
12.
Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter study.
Neurol Sci
; 41(10): 2905-2913, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32335779
13.
Prognostic indicators in pediatric clinically isolated syndrome.
Ann Neurol
; 81(5): 729-739, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28439957
14.
Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis.
Mult Scler
; 24(8): 1039-1045, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28537100
15.
Predictors of long-term disability accrual in relapse-onset multiple sclerosis.
Ann Neurol
; 80(1): 89-100, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27145331
16.
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 93(4): 448-450, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34408003
17.
Neuromyelitis optica spectrum disorders associated with systemic sclerosis: a case report and literature review.
Neurol Sci
; 43(6): 4015-4018, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35288788
18.
Immunomodulatory therapies delay disease progression in multiple sclerosis.
Mult Scler
; 22(13): 1732-1740, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-22653657
19.
Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis.
Brain
; 138(Pt 11): 3275-86, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26362907
20.
The role of neutralizing antibodies to interferon-ß as a biomarker of persistent MRI activity in multiple sclerosis: a 7-year observational study.
Eur J Clin Pharmacol
; 72(8): 1025-9, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27251359